Hizentra and Bone pain - a phase IV clinical study of FDA data

Summary:

Bone pain is reported as a side effect among people who take Hizentra (human immunoglobulin g), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Epipen, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Bone pain when taking Hizentra. It is created by eHealthMe based on reports of 23,644 people who have side effects when taking Hizentra from the FDA, and is updated regularly.

What is Hizentra?

Hizentra has active ingredients of human immunoglobulin g. eHealthMe is studying from 23,666 Hizentra users. Check the latest studies of Hizentra.

What is Bone pain?

Bone pain is found to be associated with 1,814 drugs and 1,777 conditions by eHealthMe. Check the latest studies of Bone pain.

On Jul, 04, 2026

23,644 people reported to have side effects when taking Hizentra.
Among them, 55 people (0.23%) have Bone pain.

Among these 55 people:

How long have people been on Hizentra when they have Bone pain? *

What is the gender of people who have Bone pain when taking Hizentra? *

female: 85.19 %
male: 14.81 %

What is the age of people who have Bone pain when taking Hizentra? *

What are other drugs people take besides Hizentra? *

What are other side effects people have besides Bone pain? *

Joint Pain: 21 people, 38.18%
Fatigue (feeling of tiredness): 16 people, 29.09%
Headache (pain in head): 15 people, 27.27%
Pain: 15 people, 27.27%
Sinusitis (inflammation of sinus): 13 people, 23.64%
Pain In Extremity: 12 people, 21.82%
Peripheral Swelling: 11 people, 20.00%
Nausea (feeling of having an urge to vomit): 11 people, 20.00%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 14.55%
Nausea And Vomiting: 8 people, 14.55%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 11 people, 20.00%
Immunodeficiency Common Variable: 8 people, 14.55%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 8 people, 14.55%
Immunodeficiency: 5 people, 9.09%
Secondary Immunodeficiency (lack of immunity due to some disease): 4 people, 7.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.45%
Osteoporosis (bones weak and more likely to break): 3 people, 5.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.45%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 3.64%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Hizentra and have Bone pain?

- Check whether Bone pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hizentra:

Hizentra (23,666 reports)

Bone pain treatments and more:

Bone pain (76,561 reports)

Browse all side effects of Hizentra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone pain:

Bone pain (1,815 drugs)

Browse all the conditions that are associated with Bone pain:

Bone pain (1,777 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on human immunoglobulin g (the active ingredients of Hizentra) and Hizentra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.